Clinical, Quality of Life, and Radiological Outcomes Before and After the Implementation of a Standardized Bevacizumab Protocol for Vestibular Schwannomas in NF2-related Schwannomatosis: A Single-center Experience at a Canadian Tertiary Care Institut
To describe the evolution of hearing parameters, quality of life, and vestibular schwannoma (VS) volume in patients with NF2-related schwannomatosis (NF2) before and after the implementation of a standardized protocol for disease surveillance bevacizumab administration.
Authors
- Julien Rousseau (ORCID: https://orcid.org/0000-0003-1889-018X)
- Nicolas Greciet
- S. LaPointe (ORCID: https://orcid.org/0000-0002-5440-839X)
- Issam Saliba (ORCID: https://orcid.org/0000-0002-4475-5988)
- Marie-Hélène Gosselin
- Labidi Moujahed
- Franciska Otaner
- Catherine Giasson
- Marco Perez-Caceres
- Ahmed Zaki Anwar El Haffaf
Institutions
- Mass General Brigham (US)
Publication Details
- Journal
- Neurology
- Published
- 2025-04-07
- DOI
- https://doi.org/10.1212/wnl.0000000000212306
- Primary Topic
- Meningioma and schwannoma management
- Type
- article
- Field-Weighted Citation Impact
- 0.00